|
|
Place du pathologiste dans la prise en charge du carcinome rénal en situation néoadjuvante. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma].
Xavier Leroy
,
Julien Edeline
,
Nathalie Rioux-Leclercq
Journal articles
inserm-00653252v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy
Corentin Louis
,
Julien Edeline
,
Cédric Coulouarn
Journal articles
hal-03129158v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Carcinomes à cellules rénales et facteurs pronostiques. [Renal cell carcinoma and prognostic factors]
Julien Edeline
,
Nathalie Rioux-Leclercq
Journal articles
inserm-00354469v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolution of parenteral nutrition practices in a comprehensive cancer center: Comparative audits
Alexandre Peinoit
,
Léa Muzellec
,
Mickaël Som
,
Julien Edeline
,
Ronan Thibault
,
et al.
Journal articles
hal-04061903v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential
Solène-Florence Kammerer-Jacquet
,
Laurence Crouzet
,
Angélique Brunot
,
Julien Dagher
,
Adélaide Pladys
,
et al.
Journal articles
hal-01439352v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial
Julien Edeline
,
Yann Touchefeu
,
Boris Guiu
,
Olivier Farge
,
David Tougeron
,
et al.
Journal articles
hal-02364095v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma
Gaëlle Angenard
,
Aude Merdrignac
,
Corentin Louis
,
Julien Edeline
,
Cédric Coulouarn
Journal articles
hal-02152868v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Integrative genomics highlights opportunities for innovative therapies targeting the tumor microenvironment in gallbladder cancer
Stephanie Roessler
,
Julien Edeline
,
Peter Schirmacher
,
Cédric Coulouarn
Journal articles
hal-03156698v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study
Juliette Viaud
,
Clémence Brac
,
Pascal Artru
,
Estelle Le Pabic
,
Bérengère Leconte
,
et al.
Journal articles
hal-01534249v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
La neutrophil gelatinase-associated lipocalin, ou LCN 2, facteur d'agressivité dans le carcinome rénal à cellules claires (CRCC). [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
Christophe Perrin
,
Jean-Jacques Patard
,
Florence Jouan
,
Nicolas Collet
,
Sandrine Théoleyre
,
et al.
Journal articles
inserm-00638985v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90) Y-loaded glass microsphere radioembolization
Etienne Garin
,
Yan Rolland
,
Marc Pracht
,
Samuel Le Sourd
,
Sophie Laffont
,
et al.
Journal articles
hal-01447063v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role.
Stefania de Lorenzo
,
Francesco Tovoli
,
Alessandro Mazzotta
,
Francesco Vasuri
,
Julien Edeline
,
et al.
Journal articles
hal-02998325v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization: preliminary results.
Marc Pracht
,
Julien Edeline
,
Laurence Lenoir
,
M. Latournerie
,
Habiba Mesbah
,
et al.
Journal articles
inserm-00814189v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)
Luc Beuzit
,
Julien Edeline
,
Vanessa Brun
,
Maxime Ronot
,
Anne Guillygomarc'H
,
et al.
Journal articles
hal-01363197v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.
Julien Edeline
,
Brigitte Laguerre
,
Yan Rolland
,
Jean-Jacques Patard
Journal articles
inserm-00432304v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma
Antonin Vary
,
Loïc Lebellec
,
Frédéric Di Fiore
,
Nicolas Penel
,
Claire Cheymol
,
et al.
Journal articles
hal-03367978v2
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns
Alexandra Frelau
,
Marc Pracht
,
Samuel Le Sourd
,
Alexandra Lespagnol
,
Romain Corre
,
et al.
Journal articles
hal-01815717v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
FOLFIRINOX De-Escalationin Advanced Pancreatic Cancer: A MulticenterReal-LifeStudy
Hortense Chevalier
,
Angélique Vienot
,
Astrid Lièvre
,
Julien Edeline
,
Farid El Hajbi
,
et al.
Journal articles
hal-02958602v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
Xavier Palard
,
Julien Edeline
,
Yan Rolland
,
Samuel Le Sourd
,
Marc Pracht
,
et al.
Journal articles
hal-01709935v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
Etienne Garin
,
Lambros Tselikas
,
Boris Guiu
,
Julia Chalaye
,
Julien Edeline
,
et al.
Journal articles
hal-02998830v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Adverse events of targeted therapies reported by patients with cancer treated in primary care
Emilie Roger
,
Julien Edeline
,
Boris Campillo-Gimenez
,
Elodie Ventroux
,
Marie-Eve Rouge-Bugat
,
et al.
Journal articles
hal-03127093v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CAR-T cells and BiTEs in solid tumors: challenges and perspectives
Julien Edeline
,
Roch Houot
,
Aurélien Marabelle
,
Marion Alcantara
Journal articles
hal-03228682v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
Etienne Garin
,
Yan Rolland
,
Sophie Laffont
,
Julien Edeline
Journal articles
hal-01197349v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan
Lorenzo Fornaro
,
Francesco Leone
,
Angélique Vienot
,
Andrea Casadei-Gardini
,
Caterina Vivaldi
,
et al.
Journal articles
hal-02307162v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Voies moléculaires dans le cancer du rein : de la biologie aux traitements de demain. [Signalling pathways in renal-cell carcinoma: from the molecular biology to the future therapy]
Julien Edeline
,
Cécile Vigneau
,
Jean-Jacques Patard
,
Nathalie Rioux-Leclercq
Journal articles
inserm-00480057v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|